OMRF opened the state’s first small animal magnetic resonance imaging facility
In 2004, the Oklahoma Medical Research Foundation (OMRF) opened the state’s first small animal magnetic resonance imaging facility….
World’s first use of low-dose radioactive palladium ‘seeds’ was used to treat breast cancer patients at the Women’s Research Institute in Toronto.
In 2004, the world’s first use of low-dose radioactive palladium ‘seeds’ as used to treat breast cancer patients…
William Hagopian launched The Environmental Determinants of Diabetes in the Young study
In 2004, William Hagopian, M.D., Ph.D., launched The Environmental Determinants of Diabetes in the Young (TEDDY) study at…
A novel approach to treatment of solid cancers involved therapeutic agents that inhibit the generation of new blood vessels in growing tumors
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
OHSU researcher uncovered macular degeneration gene
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
A clinical trial found post-menopausal survivors of early-stage breast cancer who took letrozole reduced risk of cancer recurrence
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
The Scripps Research Institute announced the establishment of a major science center in Palm Beach County, Florida
On Oct. 9, 2003, The Scripps Research Institute (TSRI) announced the establishment of a major science center in…
The National Center for Research Resources awarded a $67 million grant to UGA for a Parkinson’s disease study
On Sept. 4, 2003, the National Center for Research Resources (NCCR) awarded a $6.7 million grant to the…
OHSU announced results of a smallpox vaccine study on America’s preparedness for a smallpox outbreak
On Aug. 17, 2003, Oregon Health & Science University (OHSU) announced the final results of a smallpox vaccine…
Results of the Prostate Cancer Prevention Trial were announced
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
Biotechnology | Disease | FDA | Therapeutics
Genentech drug Xolair (omalizumab) was approved
On Jun. 20, 2003, Genentech drug Xolair (omalizumab) was approved by the U. S. Food and Drug Administration…
The Curious Incident of the Dog in the Night-Time was published
On May 1, 2003, Mark Haddon’s The Curious Incident of the Dog in the Night-Time was published, allowing…
International consortium completed the Human Genome Project
On Apr. 14, 2003, The International Human Genome Sequencing Consortium, led in the U.S. the National Human Genome…
Taking daily aspirin for as little as 3 years was shown to reduce the development of colorectal polyps
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
Researchers pinpointed the source of preeclampsia
On Mar. 4, 2003, Beth Israel Deaconess researchers pinpointed the source of preeclampsia, a life-threatening complication of pregnancy….
Biotechnology | Disease | HIV | Vaccine
U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) was established
On Jan. 26, 2003, President Bush, in his State of the Union Address, announced the Emergency Plan for…
Biotechnology | Disease | FDA | Medicine | Therapeutics
Long-term efficacy and safety of etanercept was found in children with polyarticular-course juvenile rheumatoid arthritis
On Jan. 10, 2003, long-term efficacy and safety of etanercept (Enbrel) was found in children with polyarticular-course juvenile…
Biotechnology | Diagnostics | Disease | Medical Device | Medicine | Non-Profit Research | Therapeutics
The Medical University of South Carolina and Clemson University established joint Bioengineering Program
In 2003, the Medical University of South Carolina and Clemson University established a joint Bioengineering Program. Located on…
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics
NCI clinical trial showed reduced intervals between chemotherapy improved survival in women whose breast cancer had spread to lymph nodes
On Dec. 12, 2002, the National Cancer Institute (NCI) announced that a clinical trial had shown that reducing…
Biotechnology | Disease | FDA
Genentech drug Pegasys (peginterferon alfa-2a) approved
On Dec. 3, 2002, Genentech drug Pegasys (peginterferon alfa-2a) was approved by the Food and Drug Administration (FDA)…
The Alberta Innovates Centre for Carbohydrate Science began operation
In Sept. 2002, the Alberta Innovates Centre for Carbohydrate Science (now Alberta Glycomics Centre), began operation with a…
The CDC reported newborn HIV infection reductions of 80% since 1981
On Jul. 9, 2002, the U.S. Centers for Disease Control and Prevention (CDC) reported newborn HIV infection reductions…
Biotechnology | Diagnostics | Disease | Life Science History | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Cancer Center received NCI designation
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
Cook County Hospital opened doors to John Stroger Hospital of Cook County
In February 2002, the doors opened to the John Stroger Hospital of Cook County, a new state-of-the-art, 464-bed,…
Los Angeles Cancer Center Received $15 Million for Woman’s Health Center
On Mar. 26, 2005, The University of Southern California/Norris Comprehensive Cancer Center in Los Angeles announced a $15…
Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania
In 2002, the Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania…
Biotechnology | Diagnostics | Disease | Medicine | Oncology | Therapeutics
The Cancer Center at Baylor College of Medicine was established
In 2002, the Cancer Center at Baylor College of Medicine, now known as the Dan L Duncan Comprehensive…
World Health Organization confirmed an outbreak of Ebola in Gabon
On Dec. 12, 2001, the World Health Organization (WHO) confirmed an outbreak of Ebola in Gabon. The WHO…
$2.5 million award from Jeld-Wen Foundation endowed OHSU Chair in Leukemia Research for Brian Druker
On Nov. 7, 2001, the Oregon Health Sciences University Foundation (OHSU) announced that the Klamath Falls-based JELD-WEN Foundation…
Biotechnology | Disease | FDA | Therapeutics
Genentech drug Cathflo Activase (alteplase) was approved
On Sept. 13, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s request for it’s…